Strong Decay of SARS-CoV-2 Spike Antibodies after 2 BNT162b2 Vaccine Doses and High Antibody Response to a Third Dose in Nursing Home Residents

OBJECTIVES: To measure the antibody decay after 2 BNT162b2 doses and the antibody response after a third vaccine dose administered 6 months after the second one in nursing home residents with and without prior COVID-19. DESIGN: Cohort study. SETTING AND PARTICIPANTS: Four hundred-eighteen residents...

Descripción completa

Detalles Bibliográficos
Autores principales: Blain, Hubert, Tuaillon, Edouard, Gamon, Lucie, Pisoni, Amandine, Miot, Stéphanie, Picot, Marie-Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2022
Materias:
Original Study - Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864102/
https://www.ncbi.nlm.nih.gov/pubmed/35311651
http://dx.doi.org/10.1016/j.jamda.2022.02.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864102/
https://www.ncbi.nlm.nih.gov/pubmed/35311651
http://dx.doi.org/10.1016/j.jamda.2022.02.006

Ejemplares similares